BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sobotka LA, Hinton A, Conteh LF. African Americans are less likely to receive curative treatment for hepatocellular carcinoma. World J Hepatol 2018; 10(11): 849-855 [PMID: 30533185 DOI: 10.4254/wjh.v10.i11.849]
URL: https://www.wjgnet.com/1948-5182/full/v10/i11/849.htm
Number Citing Articles
1
Faith Ajayi, Jenny Jan, Amit G. Singal, Nicole E. Rich. Racial and Sex Disparities in Hepatocellular Carcinoma in the USACurrent Hepatology Reports 2020; 19(4): 462 doi: 10.1007/s11901-020-00554-6
2
Mitchell L Ramsey, Michael R Wellner, Kyle Porter, Stephen E Kirkby, Susan S Li, Luis F Lara, Sean G Kelly, A James Hanje, Lindsay A Sobotka. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosisWorld Journal of Hepatology 2022; 14(2): 411-419 doi: 10.4254/wjh.v14.i2.411
3
Nicole E. Rich, Christian Carr, Adam C. Yopp, Jorge A. Marrero, Amit G. Singal. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-AnalysisClinical Gastroenterology and Hepatology 2022; 20(2): e267 doi: 10.1016/j.cgh.2020.12.029
4
Jacquelyn Carr, Da Eun Cha, Tali Shaltiel, Serena Zheng, Cleo Siderides, Benjamin Golas, Daniel Labow, Deepa Magge, Noah Cohen, Andrea Branch, Umut Sarpel. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and MortalityJournal of Immigrant and Minority Health 2022; 24(2): 327 doi: 10.1007/s10903-021-01205-8
5
Wei Yu, Sanjit K. Roy, Yiming Ma, Thomas A. LaVeist, Sharmila Shankar, Rakesh K. Srivastava. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian AmericansJournal of Cellular and Molecular Medicine 2019; 23(12): 7999 doi: 10.1111/jcmm.14652
6
Connor Griffin, Uchenna Agbim, Azaan Ramani, Nagasri Shankar, Fasiha Kanwal, Sumeet K. Asrani. Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 1999–2018Clinical Gastroenterology and Hepatology 2023; 21(1): 223 doi: 10.1016/j.cgh.2021.10.036
7
Kavin Sugumar, Sarah C. Markt, Jonathan J. Hue, Richard S. Hoehn, Richard T. Lee, Kenneth D. Chavin, Luke D. Rothermel, Jordan M. Winter, Jeffrey M. Hardacre, John B. Ammori, Lee M. Ocuin. Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinomaHPB 2022; 24(6): 925 doi: 10.1016/j.hpb.2021.10.023
8
Daniela Goyes, John Paul Nsubuga, Esli Medina-Morales, Romelia Barba, Vilas Patwardhan, Behnam Saberi, Zachary Fricker, Alan Bonder. Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception PointsJournal of Clinical Medicine 2021; 10(24): 5826 doi: 10.3390/jcm10245826
9
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomesCancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
10
Premal S. Trivedi, Bernardo Guerra, Vishal Kumar, Goke Akinwande, Derek West, Nadine Abi-Jaoudeh, Gloria Salazar, Paul Rochon. Healthcare Disparities in Interventional RadiologyJournal of Vascular and Interventional Radiology 2022; 33(12): 1459 doi: 10.1016/j.jvir.2022.08.026
11
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel Levy, Lydia Bioh, Aaron Wang, Sharmin Sultana, Andreas Kaubisch, Milan Kinkhabwala, Sarah Bellemare, Shabnam Fidvi, Devaraju Kanmaniraja, Robert Berkenblit, Jee-Young Moon, Adebola Adedimeji, Clara Tow, Yvonne Saenger. Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United StatesJournal of Hepatocellular Carcinoma 2024; : 257 doi: 10.2147/JHC.S436804
12
Liat Gutin, Francis Yao, Jennifer L. Dodge, Joshua Grab, Neil Mehta. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical InsuranceJAMA Network Open 2019; 2(8): e1910326 doi: 10.1001/jamanetworkopen.2019.10326
13
Sedra Tibi, Vivian Tieu, Suat Babayigit, Jun Ling. Influence of Health Insurance Types on Clinical Cancer Care Accessibility and Quality Using All of Us DatabaseMedicina 2024; 60(4): 623 doi: 10.3390/medicina60040623